List of insiders holdings for Outlook Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Pillai Arun Kumar Director 10% Owner | 2022-02-01 17:09:01 | 0 25,482,529 | 25,482,529 | Form 4 |
BioLexis Pte Ltd. 10% Owner | 2024-01-31 16:01:44 | 16,637,024 0 | 16,637,024 | Form 13D |
Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner | 2024-03-20 17:24:26 | 9,266,645 0 | 9,266,645 | Form 13D |
Mohan Pankaj Director 10% Owner | 2019-01-17 16:45:42 | 7,064,553 619,114 | 7,683,667 | Form 4 |
Syntone Ventures LLC 10% Owner | 2024-04-17 21:38:26 | 2,776,867 0 | 2,776,867 | Form 13D |
Dagnon Terry Chief Operations Officer | 2023-04-21 21:05:47 | 653,058 0 | 653,058 | Form 4 |
Bahrt Kenneth Chief Medical Officer | 2019-02-19 20:23:56 | 600,000 0 | 600,000 | Form 4 |
TRENARY C RUSSELL III CEO AND PRESIDENT | 2024-03-22 17:00:28 | 455,000 0 | 455,000 | Form 4 |
MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | 2018-10-24 17:02:13 | 200,000 0 | 200,000 | Form 4 |
Griffith Donald J. Director | 2016-11-28 21:59:48 | 144,926 0 | 144,926 | Form 4 |
Windisch Joerg Director | 2018-11-13 16:57:57 | 130,465 0 | 130,465 | Form 4 |
Gangloff Scott A. SVP, Development & Mfrg | 2016-12-22 18:01:49 | 118,573 0 | 118,573 | Form 4 |
THURMAN RANDY H Director | 2024-03-08 16:04:31 | 94,441 0 | 94,441 | Form 4 |
Haller Julia A Director | 2024-03-08 16:30:50 | 94,441 0 | 94,441 | Form 4 |
Huang Andong Director | 2024-03-08 16:18:39 | 94,441 0 | 94,441 | Form 4 |
Auffarth Gerd Director | 2024-03-08 16:14:48 | 94,441 0 | 94,441 | Form 4 |
Gangolli Julian S Director | 2024-03-08 16:13:00 | 94,441 0 | 94,441 | Form 4 |
Sukhtian Faisal Ghiath Director | 2024-03-08 16:08:43 | 94,441 0 | 94,441 | Form 4 |
HILZINGER KURT J Director | 2024-03-08 16:06:59 | 94,441 0 | 94,441 | Form 4 |
Bao Kogan VP, Analytical Sciences | 2016-12-22 18:00:00 | 71,739 0 | 71,739 | Form 4 |
Yamashita Elizabeth A. VP, Regulatory Affairs | 2017-12-26 17:07:26 | 64,648 0 | 64,648 | Form 4 |
Thomas Joe Director | 2019-10-07 18:10:53 | 63,207 0 | 63,207 | Form 4 |
Evanson Jeff CHIEF COMMERCIAL OFFICER | 2024-03-22 17:00:24 | 25,000 0 | 25,000 | Form 4 |
Albrecht Claudio Director | 2017-11-02 18:13:52 | 25,000 0 | 25,000 | Form 4 |
Canute Scott A Director | 2017-10-30 18:02:53 | 15,000 0 | 15,000 | Form 4 |
Dyrness Albert D. Director | 2017-10-30 18:01:52 | 15,000 0 | 15,000 | Form 4 |
Brady Todd C Director | 2017-10-30 18:03:52 | 15,000 0 | 15,000 | Form 4 |
KENYON LAWRENCE A CHIEF FINANCIAL OFFICER | 2024-03-22 17:00:22 | 12,500 0 | 12,500 | Form 4 |
Smith Hoke Robin Director | 2016-11-30 17:27:28 | 5138 0 | 5138 | Form 4 |
Haddadin Yezan Munther Director | 2024-03-29 10:39:09 | 5048.71 0 | 5048.71 | Form 4 |